2026 AdvaMed® CEO Summit

Very few golfers have achieved sustained success individually and as a team player. Current European Ryder Cup winning captain and former World Number 1, Luke Donald MBE, has bridged the two.

With meticulous planning and leadership, Luke captained the European Ryder Cup team to a stunning victory in Rome in 2023 and was subsequently appointed to captain the team again in the United States in 2025, where he became only the second Ryder Cup captain to win back-to-back tournaments. Taking
on the mantle as captain of the European Ryder Cup Team followed successive appointments as vicecaptain in 2021 and 2018, and winning the tournament as vice-captain in 2018.

Although the Ryder Cup captaincy has been at the forefront of Luke’s recent achievements, his playing career is laden with success. Despite many in the game believing he didn’t have the ‘power’ to rise to the very top of golf, Luke was World Number 1 for a cumulative total of 56 weeks and in the world top ten
for over 200 weeks. He was also the first golfer in history to top the PGA Tour and European Tour money lists in the same year, and the first Englishman to be named PGA Player of the Year. As a player in the European Ryder Cup team, Luke represented Europe four times, being part of the winning team on all four occasions. This included leading from the front in the final day singles at the ‘Miracle of Medinah’ in 2012, in what many describe as one of the greatest sporting comebacks of all-time.

A hugely inspirational speaker, Luke draws on his experience of building a high-performance team, from a group of exceptional individual players, to win the 2023 Ryder Cup, and looks at what is required to retain the trophy in the United States in 2025. He also explores the learnings and sacrifices needed to facilitate and sustain peak performance, during prosperous and lean times, and looks at why a clear strategy is paramount to success.

Tim Dugan has more than 30 years of experience dedicated to building market-leading companies in the healthcare industry. He has been actively involved in the strategic growth and development of companies across all major healthcare sectors and leads the management of Water Street’s family of companies. Prior to establishing Water Street, he was a founding partner of One Equity Partners.

Tim is a member of the board of directors of The Advanced Medical Technology Association, a trade organization that is spearheading the effort to advance medical technology to achieve healthier lives and economies around the world. On behalf of Water Street, he currently serves on the boards of directors of Alcor Scientific, enableCV, Long Grove Pharmaceuticals, Pathnostics and Viant. Tim is involved with a number of civic organizations and serves on the boards of Providence Englewood Charter School and the Chicago Botanic Garden.

He received dual bachelor’s degrees in electrical engineering and economics from Stanford University. He earned a master’s degree in business administration from the University of Chicago Graduate School of Business.

Patrick T. Harker is a distinguished scholar, academic leader, and public policy expert with a career spanning the highest levels of academia, government, and finance. He currently serves as the Rowan Distinguished Professor at the Wharton School of the University of Pennsylvania and as Director of Academic Engagement for Penn Washington, where he helps connect the University’s thought leadership with national policy discussions in the nation’s capital.

From 2015 to 2025, Dr. Harker was the 11th President and CEO of the Federal Reserve Bank of Philadelphia, where he played a pivotal role in shaping U.S. monetary policy as a member of the Federal Open Market Committee. During his tenure, he helped to guide the economy through significant challenges, including the post-Great Recession recovery, the COVID-19 pandemic, and subsequent inflationary pressures. He also spearheaded initiatives to advance economic mobility, workforce development, and financial inclusion across the Federal Reserve’s Third District and nationally.

Prior to his tenure at the Federal Reserve, Dr. Harker served for nearly a decade as President of the University of Delaware, where he led a successful campus-wide strategic transformation, significantly expanded interdisciplinary research, and forged new partnerships with industry and government. Earlier, as Dean of the Wharton School at the University of Pennsylvania, he transformed one of the world’s top business schools by enhancing global engagement, launching innovative research centers, expanding executive education, and investing in technology to support cutting-edge teaching and learning. His
leadership helped elevate Wharton’s reputation as a hub of applied knowledge, entrepreneurship, and global economic insight.

A recognized authority in management science, financial services, and economic policy, Dr. Harker has authored or co-authored more than 100 scholarly articles. His research has advanced understanding of how financial institutions can use data and modeling to improve efficiency, manage risk, and serve
customers more effectively.

Dr. Harker has also served on numerous corporate and nonprofit boards, including those in the healthcare, energy, technology, and education sectors. His governance experience spans audit, risk, and strategy committees, reflecting his deep expertise in enterprise operations and financial oversight.

Early in his career, Dr. Harker served as a White House Fellow and Special Assistant to the Director of the Federal Bureau of Investigation, gaining insight into the intersection of public policy, national security, and institutional leadership.

Dr. Harker holds a B.S., M.S., and Ph.D. in Engineering and a Master of Arts in Economics, all from the
University of Pennsylvania .

Kevin Lobo has been CEO of Stryker since October 1, 2012, and also assumed the role of Chair of the Board on July 22, 2014. He joined Stryker in 2011 and had previously been Group President of Orthopaedics. 

Kevin serves on the Board of Directors for Parker Hannifin (NYSE:PH) and the Advanced Medical Technology Association (AdvaMed). He is also a member of the Business Council. 

Kevin has a broad business career across multiple industries. After holding finance positions with KPMG, Unilever and Kraft Canada, he spent eight years with Rhone-Poulenc, including leadership roles based in Europe. He then spent eight years at Johnson & Johnson, including as President of Ethicon Endo Surgery.